PORTLAND, Ore.: PORTLAND, Ore., Dec. 28, 2021 /PRNewswire/ — Phylos®, a modern crop science company developing advanced Cannabis and hemp genetics, was selected in mg Magazine’s 50 Best Companies to Work for in Cannabis. mg […]
LINCOLN, Neb.: LINCOLN, Neb., Dec. 21, 2021 /PRNewswire-PRWeb/ — Cambium Carbon, with support from The Nature Conservancy and the Arbor Day Foundation, released its Reforestation Hub assessment reports for three pilot cities — New York […]
What do the data so far tell us about Omicron and whether it causes milder disease than previous Covid-19 variants? What can we expect to see as Omicron infections crash up against the country’s health […]
SEATTLE: SEATTLE, Dec. 23, 2021 /PRNewswire/ — Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today published research describing LMN-201, an investigational orally delivered biologic cocktail to prevent C. difficile […]
TORRANCE, Calif.–(BUSINESS WIRE)– #3Dbrain–Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally […]
COSTA MESA, Calif.–(BUSINESS WIRE)–Happy Money, a fintech company building financial tools and services for human happiness, today announced the launch of its partnership with Teachers Federal Credit Union (TFCU), Hauppauge, NY. This announcement continues to […]
They may be late, but Lundbeck is now officially in the game for preventing migraine with CGRP drugs. The FDA has OK?d eptinezumab, the prize in Lundbeck?s $2 billion acquisition of Alder. Like rival offerings […]
Immatics, in its fecund deal spree, has lured GSK, as the British drugmaker refocuses its attention on the lucrative field of oncology. On Thursday, the privately-held immuno-oncology company secured $50 million upfront in a collaboration […]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ImmunogenX is pleased to announce that patient enrollment has begun for a Phase 2b clinical trial (NCT04243551, named ?Solutions for Celiac??). This trial is funded by the National Institutes of Health?s (NIH) […]
Swiss drugmaker Novartis has joined its big pharma compatriot GSK by officially moving its UK headquarters to West London. The move to White City ? opposite Imperial College London?s campus ? was planned in 2018. […]
© 2023 Biotech Networks, LLC
